Oculis (NASDAQ:OCS – Get Free Report)‘s stock had its “buy” rating restated by Chardan Capital in a note issued to investors on Thursday,Benzinga reports. They presently have a $28.00 price target on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback